Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback